BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21708824)

  • 1. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
    Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
    Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Haptoglobin polymorphism in patients with inflammatory bowel diseases].
    Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I
    Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism in ICAM-1, PECAM-1, E-selectin, and L-selectin genes in Tunisian patients with inflammatory bowel disease.
    Khazen D; Jendoubi-Ayed S; Aleya WB; Sfar I; Mouelhi L; Matri S; Najjar T; Filali A; Gorgi Y; Abdallah TB; Ayed K
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):167-75. PubMed ID: 19212205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency.
    Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C
    Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
    Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
    Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
    Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
    Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease.
    Vetrano S; Rescigno M; Cera MR; Correale C; Rumio C; Doni A; Fantini M; Sturm A; Borroni E; Repici A; Locati M; Malesci A; Dejana E; Danese S
    Gastroenterology; 2008 Jul; 135(1):173-84. PubMed ID: 18514073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.
    Mazzoccoli G; Palmieri O; Corritore G; Latiano T; Bossa F; Scimeca D; Biscaglia G; Valvano MR; D'Incà R; Cucchiara S; Stronati L; Annese V; Andriulli A; Latiano A
    Chronobiol Int; 2012 Oct; 29(8):994-1003. PubMed ID: 22881285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
    Mittal RD; Bid HK; Ghoshal UC
    Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease.
    Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT
    Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a CXCL9 polymorphism with pediatric Crohn's disease.
    Lacher M; Kappler R; Berkholz S; Baurecht H; von Schweinitz D; Koletzko S
    Biochem Biophys Res Commun; 2007 Nov; 363(3):701-7. PubMed ID: 17892861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A NFKB1 promoter polymorphism is involved in susceptibility to ulcerative colitis.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Int J Immunogenet; 2005 Dec; 32(6):401-5. PubMed ID: 16313306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of the K469E polymorphism of intercellular adhesion molecule 1 gene in Italian patients with inflammatory bowel disease.
    Papa A; Pola R; Flex A; Danese S; Armuzzi A; Gaetani E; Guidi L; De Vitis I; Urgesi R; Grillo A; Serricchio M; Proia AS; Fedeli G; Gasbarrini G; Pola P; Gasbarrini A
    Dig Liver Dis; 2004 Aug; 36(8):528-32. PubMed ID: 15334773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.
    Eri R; Jonsson JR; Pandeya N; Purdie DM; Clouston AD; Martin N; Duffy D; Powell EE; Fawcett J; Florin TH; Radford-Smith GL
    Genes Immun; 2004 Sep; 5(6):444-50. PubMed ID: 15215889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
    Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
    J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.